We are live on ! Find out more
TOBAM

TOBAM Portfolio holdings

AUM $244M Turnover 23.99%
1-Year Est. Return 22.99%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+22.99%
3 Year Est. Return
+76.51%
5 Year Est. Return
+69.97%
10 Year Est. Return
+288.16%
AUM
$1.33B
AUM Growth
-$191M
Cap. Flow
-$172M
Cap. Flow %
-12.94%
Top 10 Hldgs %
28.25%
Holding
397
New
37
Increased
97
Reduced
153
Closed
38
Avg Time Held
2.2 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.8 years

Top Sells

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$21.8M
2
DGX icon
Quest Diagnostics
DGX
+$15M
3
DLTR icon
Dollar Tree
DLTR
+$12.5M
4
BIIB icon
Biogen
BIIB
+$10.8M
5
GEN icon
Gen Digital
GEN
+$10.5M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Consumer Staples 24.84%
3 Technology 8.65%
4 Financials 6.98%
5 Communication Services 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MRK icon
1
Merck
MRK
$330B
$40.9M 3.08%
354,148
-62,424
-15% -$7.09M
2020 Q3
11 quarters
K icon
2
DELISTED
Kellanova
K
$38.4M 2.89%
569,091
-65,591
-10% -$4.45M
2016 Q1
29 quarters
GIS icon
3
General Mills
GIS
$19.1B
$38M 2.86%
494,966
-35,173
-7% -$3.01M
2018 Q3
19 quarters
PFE icon
4
Pfizer
PFE
$156B
$37.9M 2.86%
1,032,663
-35,284
-3% -$1.37M
2020 Q3
11 quarters
CLX icon
5
Clorox
CLX
$12.7B
$37.8M 2.85%
237,975
-33,367
-12% -$5.38M
2014 Q3
35 quarters
ABBV icon
6
AbbVie
ABBV
$506B
$37.4M 2.82%
277,792
+57,004
+26% +$8.36M
2020 Q3
11 quarters
CHD icon
7
Church & Dwight
CHD
$26.2B
$36.8M 2.77%
366,994
-95,016
-21% -$8.95M
2018 Q1
21 quarters
JNJ icon
8
Johnson & Johnson
JNJ
$651B
$36.7M 2.77%
221,793
-5,145
-2% -$830K
2020 Q3
11 quarters
BMY icon
9
Bristol-Myers Squibb
BMY
$120B
$36.4M 2.75%
569,913
-19,661
-3% -$1.32M
2016 Q4
26 quarters
NEM icon
10
Newmont
NEM
$98.4B
$34.4M 2.6%
806,989
+93,395
+13% +$4.24M
2013 Q2
40 quarters
UTHR icon
11
United Therapeutics
UTHR
$23.6B
$32.8M 2.47%
148,493
-21,430
-13% -$4.75M
2022 Q2
4 quarters
TTWO icon
12
Take-Two Interactive
TTWO
$39.3B
$32.6M 2.46%
221,455
-72,342
-25% -$9.46M
2020 Q2
12 quarters
SJM icon
13
J.M. Smucker
SJM
$14.3B
$31M 2.34%
210,258
-18,268
-8% -$2.79M
2018 Q4
18 quarters
KR icon
14
Kroger
KR
$40.4B
$29.7M 2.24%
631,391
+255,022
+68% +$12.2M
2016 Q1
29 quarters
NBIX icon
15
Neurocrine Biosciences
NBIX
$15.2B
$29.4M 2.22%
311,715
-50,689
-14% -$4.95M
2018 Q4
18 quarters
GEN icon
16
Gen Digital
GEN
$17.3B
$29.1M 2.2%
1,569,525
-599,761
-28% -$10.5M
2018 Q2
20 quarters
CPB icon
17
Campbell's
CPB
$7.11B
$29.1M 2.19%
636,579
-103,441
-14% -$5.33M
2016 Q2
28 quarters
HUM icon
18
Humana
HUM
$46.8B
$27.1M 2.04%
60,566
-7,155
-11% -$3.6M
2013 Q2
40 quarters
CHRW icon
19
C.H. Robinson
CHRW
$15.5B
$26M 1.96%
275,113
-60,585
-18% -$5.86M
2019 Q4
14 quarters
HRL icon
20
Hormel Foods
HRL
$13B
$25.1M 1.89%
623,370
-161,764
-21% -$6.49M
2020 Q2
12 quarters
SLB icon
21
SLB
SLB
$67.7B
$23.8M 1.79%
484,554
-60,835
-11% -$2.9M
2020 Q3
11 quarters
FSLR icon
22
First Solar
FSLR
$14.8B
$22.7M 1.71%
119,359
+22,701
+23% +$4.5M
2022 Q3
3 quarters
HSY icon
23
Hershey
HSY
$35.3B
$21.8M 1.64%
87,158
+7,802
+10% +$2.05M
2017 Q1
25 quarters
AIZ icon
24
Assurant
AIZ
$15.5B
$21.2M 1.6%
168,936
-33,756
-17% -$4.2M
2022 Q1
5 quarters
MCK icon
25
McKesson
MCK
$123B
$21.2M 1.6%
49,587
+5,916
+14% +$2.27M
2022 Q3
3 quarters

Similar funds

TOBAM's Q2 2023 Portfolio in Review

As of Q2 2023, TOBAM held 397 positions worth $1.33B, down 13% from $1.52B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

TOBAM withdrew a net $172M in Q2 2023, closing 38 positions and reducing 153 holdings. Its most notable exit was argenx, an estimated $2.75M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, TOBAM opened a new position in Advance Auto Parts worth $10.2M.

  • TOBAM's largest Q2 2023 buy was Advance Auto Parts: 145,601 shares worth $10.2M.
  • TOBAM added most to Kroger in Q2 2023, an estimated $12.2M increase.
  • TOBAM's biggest Q2 2023 reduction was Kimberly-Clark, cutting an estimated $21.8M.
  • TOBAM fully exited argenx in Q2 2023, selling an estimated $2.75M.
  • TOBAM's ten largest holdings make up 28% of its $1.33B portfolio in Q2 2023.
  • TOBAM opened 37 new positions and closed 38 in Q2 2023.
  • TOBAM's portfolio value fell 13% quarter-over-quarter to $1.33B.

Based on TOBAM's 13F filing for Q2 2023, filed 31 Jul 2023.